These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20030907)

  • 1. A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.
    Toner E; Brennan GP; McConvery F; Meaney M; Fairweather I
    Parasitology; 2010 Apr; 137(5):855-70. PubMed ID: 20030907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.
    Toner E; McConvery F; Brennan GP; Meaney M; Fairweather I
    Parasitology; 2009 Apr; 136(5):523-35. PubMed ID: 19272211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
    O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I
    J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica.
    Meaney M; Haughey S; Brennan GP; Fairweather I
    Parasitol Res; 2005 Feb; 95(3):201-12. PubMed ID: 15645289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
    Alvarez LI; Solana HD; Mottier ML; Virkel GL; Fairweather I; Lanusse CE
    Parasitology; 2005 Oct; 131(Pt 4):501-10. PubMed ID: 16174415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2011 May; 177(3-4):305-15. PubMed ID: 21208747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2012 Feb; 184(1):37-47. PubMed ID: 21872399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitology; 2011 Feb; 138(2):224-36. PubMed ID: 20946692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitology; 2010 Apr; 137(5):871-80. PubMed ID: 20025819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2014 Jul; 141(8):1064-79. PubMed ID: 24889697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
    Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2011 Oct; 109(4):981-95. PubMed ID: 21442257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
    Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Castillo R; Hernández-Campos A; Fairweather I
    Parasitology; 2009 May; 136(6):665-80. PubMed ID: 19368745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica.
    Meaney M; Haughey S; Brennan GP; Fairweather I
    Parasitol Res; 2005 Jan; 95(2):117-28. PubMed ID: 15592937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.